Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 9.12
-0.47 (-4.90%)
Jan 22, 2026, 1:04 PM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 4.01 billion as of January 21, 2026. Its market cap has decreased by -23.80% in one year.
Market Cap
4.01B
Enterprise Value
3.86B
Revenue
246.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
9.12
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has decreased from 5.10B to 4.01B, a decrease of -21.37%. That is a compound annual growth rate of -7.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.77B | 8.43% |
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Laboratories | 7.05B |
| Orient Pharma | 6.56B |
| SCI Pharmtech | 6.35B |
| Easywell Biomedicals | 4.33B |
| Orient EuroPharma | 3.87B |
| Maywufa Company | 2.91B |
| Golden Biotechnology | 2.90B |
| PhytoHealth | 2.78B |